I was reviewing last Q's call and ran across this, which I had previously overlooked.
"So, let's turn our attention to the current active programs we have with new and existing customers. At the end of the fiscal year on June 30, 2014, we had 12 active programs with 11 different customers. Since our last earnings call in May, we started an additional two programs (makes 14 total). Furthermore, I can also advise that some additional programs have commenced since July 1, 2014. But we will highlight these new programs on the next earnings call."
Two things jump out. 1) As of last quarter's conference call, we had 15 deals (and with the recent Sanofi deal, we are at 16, and 2) Alan will "highlight these new programs" on today's earnings call.
Hopefully Alan will give us details on prodution capacity and FDA approval process/status.
UNS Price at posting:
70.5¢ Sentiment: Hold Disclosure: Held
